Optical sensor for in vivo detection of analyte

US9399076B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9399076-B2
Application numberUS-59658905-A
CountryUS
Kind codeB2
Filing dateMay 17, 2005
Priority dateMay 19, 2004
Publication dateJul 26, 2016
Grant dateJul 26, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A sensor for the in vivo detection of glucose comprises: components of an assay for glucose, a readout of which is a detectable optical signal which can be interrogated transcutaneously by external optical means when the sensor is implanted in vivo; and a shell of biodegradable material encapsulating the assay components while allowing analyte to contact the assay components, wherein the biodegradable material comprises a co-polymer having hydrophobic and hydrophilic units. A method of preparing such a sensor preferably comprises coacervation, solvent evaporation and/or extraction, spray drying, spray coating, spray chilling, rotary disk atomisation, fluid bed coating, coextrusion and/or pan coating. A method of detecting glucose using such a sensor suitably comprises implantation of the sensor into the skin of a mammal, transdermal detection or measurement of glucose using external optical means and degradation of the biodegradable material.

First claim

Opening claim text (preview).

The invention claimed is: 1. A sensor for the in vivo detection of glucose, comprising: components of an assay for glucose, a readout of which is a detectable optical signal which can be interrogated transcutaneously by external optical means when the sensor is implanted in vivo; and a shell of biodegradable material encapsulating the assay components whilst allowing an analyte to contact the assay components, wherein the biodegradable material comprises a co-polymer having hydrophobic units and hydrophilic units, the hydrophilic units each comprising an ester of polyethylene glycol and a diacid. 2. A sensor as claimed in claim 1 , wherein the co-polymer is a random co-polymer. 3. A sensor as claimed in claim 1 , wherein the co-polymer has a molecular weight cut-off limit of no more than 25000 Da. 4. A sensor as claimed in claim 3 , wherein the co-polymer has a molecular weight cut-off limit of no more than 10000 Da. 5. A sensor as claimed in claim 1 , wherein the co-polymer has a permeability of at least 5.0×10 −10 cm 2 /s. 6. A sensor as claimed in claim 1 , wherein the weight fraction of the hydrophobic units is from 10 to 90% of the co-polymer. 7. A sensor as claimed in claim 1 , wherein the hydrophilic units comprise terephthalic acid and/or succinic acid as diacids. 8. A sensor as claimed in claim 7 , wherein the hydrophilic units comprise terephthalic acid only as the diacid. 9. A sensor as claimed in claim 7 , wherein the ratio of terephthalic acid to succinic acid in the hydrophilic units is between 1:2 and 2:1. 10. A sensor as claimed in claim 7 , wherein the hydrophilic units comprise terephthalic acid and succinic acid as diacids. 11. A sensor as claimed in claim 1 , wherein the molecular weight of each hydrophilic unit is from 400 to 4000 Da. 12. A sensor as claimed in claim 1 , wherein the hydrophobic units of the co-polymer comprise an ester of butane-1,4-diol and a diacid. 13. A sensor as claimed in claim 12 , wherein the hydrophobic units comprise terephthalic acid and/or succinic acid as diacids. 14. A sensor as claimed in claim 13 , wherein the hydrophobic units comprise terephthalic acid only as the diacid. 15. A sensor as claimed in claim 13 , wherein the ratio of terephthalic acid to succinic acid is between 1:2 and 2:1. 16. A sensor as claimed in claim 1 , wherein the assay is a binding assay. 17. A sensor as claimed in claim 16 , wherein the binding assay is a competitive binding assay, the components of which include a glucose binding agent and a glucose analogue. 18. A sensor as claimed in claim 17 wherein the glucose analogue is labelled with a first chromophore and the glucose binding agent is labelled with a second chromophore, the emission spectrum of the first chromophore or second chromophore overlapping with the absorption spectrum of the second chromophore or first chromophore respectively. 19. A sensor as claimed in claim 17 , wherein the binding agent is an antibody, a Fab fragment, a lectin, a hormone receptor, a drug receptor, an aptamer or a molecularly-imprinted polymer. 20. A sensor as claimed in claim 1 , wherein the detectable or measurable optical signal is generated by fluorescence resonance energy transfer, fluorescence polarisation, fluorescence quenching, phosphorescence, luminescence enhancement, luminescence quenching, diffraction or plasmon resonance. 21. A method of preparing a sensor as claimed in claim 1 , where the method comprises forming the shell of biodegradable material of claim 1 by forming an open hollow shell of co-polymer, filling the shell with assay components and sealing the shell to make the sensor. 22. A method of detecting glucose using a sensor as claimed in claim 1 , comprising implanting the sensor into the skin of a mammal, transdermally detecting or measuring glucose using external optical means and degrading the biodegradable material. 23. A method of detecting glucose using a sensor as claimed in claim 1 , comprising transdermally detecting or measuring glucose using external optical means by illumination of said sensor present in or below the skin of a mammal.

Assignees

Inventors

Classifications

  • for measuring glucose, e.g. by tissue impedance measurement · CPC title

  • Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9399076B2 cover?
A sensor for the in vivo detection of glucose comprises: components of an assay for glucose, a readout of which is a detectable optical signal which can be interrogated transcutaneously by external optical means when the sensor is implanted in vivo; and a shell of biodegradable material encapsulating the assay components while allowing analyte to contact the assay components, wherei…
Who is the assignee on this patent?
Yu Yihua, Kristensen Jesper S, Medtronic Minimed Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/14532. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).